PT801575E - Vectores retrovirais para expressao em celulas embrionarias - Google Patents

Vectores retrovirais para expressao em celulas embrionarias

Info

Publication number
PT801575E
PT801575E PT95944182T PT95944182T PT801575E PT 801575 E PT801575 E PT 801575E PT 95944182 T PT95944182 T PT 95944182T PT 95944182 T PT95944182 T PT 95944182T PT 801575 E PT801575 E PT 801575E
Authority
PT
Portugal
Prior art keywords
vector
retroviral
embryonic cells
expression
virus
Prior art date
Application number
PT95944182T
Other languages
English (en)
Inventor
Donald B Kohn
Pia M Challita
Original Assignee
Los Angeles Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Angeles Childrens Hospital filed Critical Los Angeles Childrens Hospital
Publication of PT801575E publication Critical patent/PT801575E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/11011Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT95944182T 1994-12-21 1995-12-19 Vectores retrovirais para expressao em celulas embrionarias PT801575E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/361,112 US5707865A (en) 1994-12-21 1994-12-21 Retroviral vectors for expression in embryonic cells

Publications (1)

Publication Number Publication Date
PT801575E true PT801575E (pt) 2006-08-31

Family

ID=23420695

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95944182T PT801575E (pt) 1994-12-21 1995-12-19 Vectores retrovirais para expressao em celulas embrionarias

Country Status (11)

Country Link
US (1) US5707865A (pt)
EP (1) EP0801575B1 (pt)
JP (1) JPH10510995A (pt)
AT (1) ATE323776T1 (pt)
AU (1) AU693317B2 (pt)
CA (1) CA2208210A1 (pt)
DE (1) DE69534948T2 (pt)
DK (1) DK0801575T3 (pt)
NZ (1) NZ300795A (pt)
PT (1) PT801575E (pt)
WO (1) WO1996019245A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5703796A (en) * 1995-05-10 1996-11-29 Introgene B.V. Improved retroviral vectors, especially suitable for gene th erapy
WO1996038545A1 (en) * 1995-06-02 1996-12-05 Wakunaga Seiyaku Kabushiki Kaisha Cells producing recombinant retrovirus
US7129043B1 (en) * 1998-10-22 2006-10-31 Duke University Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6537785B1 (en) 1999-09-14 2003-03-25 Genzyme Glycobiology Research Institute, Inc. Methods of treating lysosomal storage diseases
WO2002097050A2 (en) 2001-05-31 2002-12-05 Novartis Ag Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
US6905856B2 (en) * 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US20040009158A1 (en) * 2002-07-11 2004-01-15 Washington University Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
SG11201700724PA (en) 2014-07-31 2017-02-27 Univ Oklahoma High isomerohydrolase activity mutants of mammalian rpe65
CN110607394A (zh) * 2018-06-15 2019-12-24 云舟生物科技(广州)有限公司 莫洛尼鼠白血病病毒滴度检测试剂盒及滴度检测方法
WO2025059113A1 (en) 2023-09-12 2025-03-20 The Board Of Regents Of The University Of Oklahoma Treatments for enhancing immune response to clostridioides difficile infections

Also Published As

Publication number Publication date
JPH10510995A (ja) 1998-10-27
DE69534948T2 (de) 2006-11-16
DK0801575T3 (da) 2006-08-21
AU693317B2 (en) 1998-06-25
EP0801575A1 (en) 1997-10-22
ATE323776T1 (de) 2006-05-15
NZ300795A (en) 2001-08-31
CA2208210A1 (en) 1996-06-27
EP0801575B1 (en) 2006-04-19
WO1996019245A1 (en) 1996-06-27
DE69534948D1 (de) 2006-05-24
AU4604696A (en) 1996-07-10
US5707865A (en) 1998-01-13
EP0801575A4 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
GB2331522A (en) Lentiviral vectors
PT801575E (pt) Vectores retrovirais para expressao em celulas embrionarias
Wimmer et al. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b
BG103397A (en) Retroviral vectors
CY1107760T1 (el) Κυτταρα φακοϊικου εγκλεισμου
ES2170856T3 (es) Vectores retroviricos.
CA2145661A1 (en) Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
EP0347365A3 (en) Hiv-2 virus variants
FI940867A0 (fi) Ilmentämisrakenteita, jotka sisältävät HIV:iä estäviä antisense- ja muita nukleotidisekvenssejä, retrovirusvektoreita ja näitä sisältäviä yhdistelmäretroviruksia
ATE244310T1 (de) Retrovirale vektorhybride und deren verwendung zum gentransfer
WO2000040741A3 (en) Lentivirus vector system
DK0975783T3 (da) Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
AU3693689A (en) Compositions having use as treatment of psoriasis and neuropsychiatric deficits
DK0880594T3 (da) Retroviral vektor og dens anvendelse i genterapi
WO2000001835A3 (en) Targeted integration into chromosomes using retroviral vectors
GB2363608A (en) Improved retroviral production
SU922643A1 (ru) Генератор развертки
Yu et al. High Efficiency Retroviral Vectors with Improved Safety
CA2199131A1 (en) Retroviral vector hybrids and the use thereof for gene transfer
Wood Private Groups Face Off in Brazilian Petrochemical Battle